Persistent Sore Throat Evaluation and Management

Introduction to Persistent Sore Throat

A 2-week duration of sore throat in an elderly patient is atypical and demands immediate evaluation for serious complications and non-infectious causes, not empiric antibiotic therapy, as recommended by the American College of Physicians 1
Most acute pharyngitis resolves within less than one week, with over 80% of patients achieving complete symptom resolution by 7 days, according to the Infectious Diseases Society of America 2, 1

The 2-week persistence of sore throat makes simple pharyngitis highly unlikely and mandates a different diagnostic approach, as suggested by the American Academy of Family Physicians 1
The European Society of Clinical Microbiology and Infectious Diseases guideline specifically excludes recurrent or persistent cases from their diagnostic and treatment algorithms, emphasizing the need for a tailored approach 1

Persistence beyond 2 weeks without other symptoms warrants consideration of malignancy, particularly concerning in elderly patients with isolated persistent symptoms, as highlighted by the American Cancer Society 1
Gastroesophageal reflux disease (GERD) can present as chronic throat irritation without classic heartburn, and should be considered in the differential diagnosis, according to the American Gastroenterological Association 1

Ibuprofen or acetaminophen remain first-line for pain relief regardless of the underlying etiology, as recommended by the American Academy of Pediatrics and the American Academy of Family Physicians 4, 5, 6
However, in elderly patients, exercise caution with NSAIDs due to cardiovascular risk, nephrotoxicity, gastrointestinal toxicity, and drug interactions, as advised by the American Geriatrics Society 7

Should testing reveal active streptococcal infection, penicillin V 250-500mg twice or three times daily for 10 days remains first-line treatment, as recommended by the Infectious Diseases Society of America and the American Academy of Family Physicians 4, 3
However, at 2 weeks duration, the modest antibiotic benefit for symptom reduction is clinically irrelevant, as noted by the American College of Physicians and the Infectious Diseases Society of America 2, 1